BACE-1 inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBACE-1 inhibitors (Bristol-Myers Squibb)
Drug Alias NameBACE-1 inhibitors (BMS)BMS-596116BMS-599240BMS-711603BMS-734313 +[20] 
ClassificationSmall molecules
Mechanisms of ActionBeta-secretase 1 inhibitorsBeta amyloid A4 protein inhibitors
TargetsBeta-secretase 1Beta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A